2m 2m 2m 2m 2m 2m 2m
Opus Genetics (IRD)
NASDAQ
$5.39+$0.21 (+4.05%)
Price as of Sep 21, 2026 9:50 AM EDT- $431.0MMarket Cap
- 240.79%1-Year Change
- BiotechnologyIndustry
Opus Genetics (IRD)
$5.39+$0.21 (+4.05%)
IRD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.18 | ||
Change | -$0.10 (-1.89%) | ||
Open | $5.29 | ||
High | $5.34 | ||
Low | $5.11 | ||
Previous Close | $5.28 | ||
Volume | 5,543,229 | ||
30-Day Average Volume | 4,667,852 | ||
1-Week Change | -14.24% | ||
1-Month Change | 40.38% | ||
1-Year Change | 240.79% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 83.2M | ||
Total Assets | $93.0M | ||
Market Cap | $431.0M | ||
Enterprise Value | $377.1M | ||
Period: QTR TTM FY | |||
Revenue | $755,000.00 | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$11.9M | ||
EBIT | -$8.0M | ||
EBITDA | -$8.0M | ||
Net Working Capital | $85.1M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | 499 | ||
P/B | -33 | ||
P/E | -37 | ||
PEG | -0 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue